Clinical trial
Special Drug Use Investigation for ARIXTRA® (Fondaparinux) Injection
NCT01420809 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Special Drug Use Investigation for ARIXTRA® (Fondaparinux) Injection
- Lead sponsor
- GlaxoSmithKline
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2007
- Completion date
- August 31, 2009
- Enrollment
- 1,280 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.